Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Gary Veron

ID: 1b834081-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

FDA to consider patent listing, therapeutic equivalence, and other Orange Book issues; agency will issue draft guidance documents, seek public comment

Focus on Regulation · February 4, 2019

Four new FDA guidances and proposed rule advance biosimilars policy framework

Focus on Regulation · December 11, 2018

FDA launches Biosimilars Action Plan to spur biologics competition, finalizes labeling guidance

Focus on Regulation · August 9, 2018

Supreme Court Issues Landmark Biosimilar Ruling

Biosimilars Law Blog · June 13, 2017

Guide to Recent Biosimilar Activity by FDA and in the Supreme Court

Biosimilars Law Blog · March 16, 2017

Previous

12

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog